Research
CAR-T Therapy: Mixed Results in Rheumatoid Arthritis Trial
The Brief
- A trial of CAR T-cell therapy in rheumatoid arthritis showed mixed results, according to research presented in Orlando.
- The research suggested that rheumatoid arthritis may not respond to CAR T-cell therapy as well as lupus and certain other autoimmune conditions have.
- The source is a meeting report from MedPage Today, published 2026-11-10.
Why it matters
CAR T-cell therapy has drawn interest as a treatment for autoimmune diseases, so results suggesting weaker effects in rheumatoid arthritis matter for how researchers prioritise and interpret trials in that field.
Who’s affected
- rheumatologists
- researchers developing CAR T-cell therapies for autoimmune disease
- #car-t
- #rheumatoid arthritis
- #autoimmune disease
- #clinical trial
- #immunotherapy
(MedPage Today) -- ORLANDO -- Rheumatoid arthritis (RA) may not be as amenable to chimeric antigen receptor (CAR) T-cell therapy as has been the case in lupus and certain other autoimmune conditions, research presented here suggested. Among...